The clinical features of progressive supranuclear palsy vasoconstrictor failure in PSP subjects, unlike MSA subjects, although the pressor response to mental (PSP) overlap with other parkinsonian syndromes, including multiple system atrophy (MSA). Autonomic arithmetic was reduced. Cardiac parasympathetic function was affected in only a minority (three of 35) of dysfunction is a characteristic of MSA, but has also been described in PSP. We therefore report results from a PSP subjects and was abnormal in MSA subjects. After clonidine administration, growth hormone rose in PSP series of physiological studies of cardiovascular autonomic function in 35 PSP and 20 MSA subjects, and 26 agesubjects (median increase 4.3; interquartile range 1.8-7.8 mU/l) and controls, unlike MSA subjects (0.9; 0.3-2.4 matched healthy control subjects. The response to growth hormone-clonidine testing, a neuropharmacomU/l; P < 0.005, Mann-Whitney U-test). In conclusion, in PSP subjects, responses to both physiological and logical assessment of central adrenoceptor function, was also assessed in 14 PSP and 10 MSA subjects, and pharmacological tests provided evidence against widespread autonomic dysfunction; this differed compared with 10 controls. None was on medication which may have affected the results. Orthostatic hypotension did markedly from MSA subjects. Thus, cardiovascular autonomic dysfunction should be an exclusionary feature not occur in PSP subjects or controls, unlike MSA subjects. Overall there was no evidence of sympathetic in the diagnosis of PSP.
Introduction
In patients presenting with parkinsonian features, autonomic to levodopa (Lees, 1987) . Also in PSP, abnormalities of cardiovascular and sudomotor autonomic reflexes have been dysfunction has significant implications for diagnosis, prognosis and management . In multiple reported; these include a postural blood pressure fall (Gutrecht, 1992) , an impaired heart rate response on standing system atrophy (MSA), autonomic failure is a characteristic feature, as based on numerous physiological, pharmacological (van Dijk et al., 1991) , a diminished pressor response to isometric exercise (van Dijk et al., 1991; Gutrecht, 1992 ) and neurochemical studies (Mathias, 1996; Mathias and Williams, 1994; Polinsky, 1999) . In progressive supranuclear and an abnormal skin sympathetic response (Sasaki et al., 1994) . Despite these reports of autonomic dysfunction, recent palsy (PSP), there may be overlapping neurological features with MSA, especially in the early stages, and these include publications of both clinical and neuropathologically based criteria for the diagnosis of PSP (Hauw et al., 1994 ; Collins a bilateral akinetic rigid syndrome which is poorly responsive et Litvan et al., 1996) list unexplained dysautonomia and 10 age-and sex-matched normal controls (mean age (including postural hypotension) as a mandatory exclusion 61 Ϯ 1.0, male/female ratio 2.3 : 1). criterion. There have been no detailed studies of cardiovascular autonomic function in a large cohort of PSP patients, and we report our observations using a series of Methods physiological tests (Mathias and Bannister, 1999) . Additionally, we studied the growth hormone (GH) response
Physiological tests of cardiovascular autonomic
to clonidine as an impaired response is an indicator of function central autonomic failure, as demonstrated previously in
Testing was carried out in a dedicated autonomic laboratory. MSA subjects (Kimber et al., 1997) . The physiological, BP and heart rate were measured intermittently using an pharmacological and neurohormonal responses in PSP automated device (Sentron, Bard Biochemical, USA), which subjects have been compared with subjects with MSA and was calibrated against a mercury sphygmomanometer and with age-and sex-matched healthy normal subjects.
also continuously recorded using a Finapres device (Ohmeda, USA). The changes with physiological stimuli included headup tilt for 10 min, standing for 5 min, isometric exercise, cutaneous cold, mental arithmetic, deep breathing and the
Subjects
Valsalva manoeuvre, that were performed as previously Three groups of subjects were studied. Thirty-five subjects described (Mathias and Bannister, 1999) . [mean age 65.5 Ϯ 1.3 (SEM) years, male/female ratio 2 : 1] had typical clinical features of PSP Litvan et al., 1996) were studied. The mean duration of disease was 3.8 Ϯ 0.6 years and mean Hoehn and Yahr score Neuropharmacological challenge with clonidine (Hoehn and Yahr, 1967) was 3.1 Ϯ 0.3. None previously had Subjects were studied on a separate occasion, after an taken neuroleptic drugs, abused alcohol or had more than overnight fast. BP and heart rate were measured by automated one family member with parkinsonism. Subjects were neither syphgmomanometer (Sentron). An antecubital vein cannula obese nor underweight and were not clinically depressed was sited for collection of blood samples and infusion of at the time of testing. None had pyramidal or cerebellar drugs. After a 15 min supine equilibration period, clonidine dysfunction or abnormal reflexes. All had a poor response to (2 µg/kg) was given intravenously over 10 min (Kimber anti-parkinsonian treatment and none had taken L-dopa, et al., 1997) and blood samples for analysis collected at dopaminergic agonists or anticholinergic medication within 1 15 min intervals, centrifuged at 0°C and stored at -70°C month of the study. All female subjects were post-menopausal. until analysed. Samples from each subject were tested in Twenty MSA subjects with parkinsonian and autonomic the same assay run. Plasma catecholamines (noradrenaline, features (mean age 60 Ϯ 6.7 years, male/female ratio 2 : 1) adrenaline and dopamine) were measured using highalso were studied. The mean duration of disease was 4.5 Ϯ 1.1 performance liquid chromatography with an electrochemical years and mean Hoehn and Yahr score was 3.5 Ϯ 0.5. All detector (May et al., 1988) , plasma glucose by the glucose had a symptomatic fall in systolic blood pressure (BP) oxidase method with a Chem Lab autoanalyser (Hornchurch, (of Ͼ20 mmHg) on standing and an abnormal plasma Essex, UK) and serum GH by 131 I-labelled GH immunonoradrenaline response to head-up tilt. Also, all had urinary radiometric assay kit (Netria, London, UK). Plasma growth bladder symptoms, impotence (in males), hypohidrosis, and hormone releasing hormone (GHRH), thyroid stimulating bilateral akinesia and muscular rigidity with minimal or no hormone (TSH), prolactin and insulin-like growth factor-1 tremor; the majority had additional cerebellar features. They (IGF-1) were also measured radioimmmunometrically. The had a suboptimal clinical response to L-dopa and none had inter-and intra-personal assay variations were, respectively, been taking antiparkinsonian medication for Ͼ1 month.
4.7 and 4.3% for noradrenaline, 4.6 and 5.1% for adrenaline, Secondary causes of autonomic dysfunction (e.g. diabetes 6.4 and 5.8% for dopamine, 4.8 and 3.2% for glucose, 5.4 mellitus) were excluded (Mathias, 2000) . and 7.4% for GH, 5.5 and 4% for TSH, 2.6 and 2.1% for Twenty-six healthy normal subjects matched for age and prolactin, 5 and 7% for IGF-1. sex (mean age 67 Ϯ 5 years, male/female ratio 2 : 1) were studied as controls. None was on drugs. All subjects gave informed consent and the study was approved by the ethics committees at The National Hospital for Neurology and
Statistical analysis
Neurosurgery and St Mary's Hospital Analysis of summary measures of outcome was by Student's Cardiovascular autonomic testing was performed in each t-test for parametric data and Mann-Whitney U-test for nonsubject. In addition, neuropharmacological challenge with parametric parameters, using Minitab for Microsoft Windows clonidine was carried out in a subgroup of 14 PSP subjects 95. Unless specified, values are means and (Ϯ) standard error (mean age 65 Ϯ 1.0 years, male/female ratio 3.5 : 1), 10 MSA subjects (mean age 65 Ϯ 1.0, male/female ratio 2.3 : 1) of mean. BP is presented in mmHg and heart rate in beats/min. Isometric hand grip Systolic 13 (2) 14 (2) 9 (3) Diastolic 9 (1)
Heart rate responses to respiratory stimuli
Mental arithmetic
The heart rate change expressed as the Valsalva ratio during Systolic 16 (2) 9 (2)* -2 (3)* and following a Valsalva manoeuvre was similar in conDiastolic 7 (1) 6 (1) -1 (1)* trols and PSP subjects, but was lower in MSA subjects
(1) Cutaneous cold (P Ͻ 0.05). There were no heart rate variability differences Systolic 14 (3) 13 (2) 12 (3) during deep breathing between controls and PSP subjects,
unlike MSA subjects in whom it was significantly reduced
05). Individual analysis indicated that out of 35 PSP
Heart rate changes to respiratory stimuli cases, only four had a subnormal Valsalva ratio (Ͻ1.15); these Deep breathing (∆HR) 11 (2) 9 (1) 3 (1)* subjects also had reduced sinus arrhythmia (Ͻ5 beats/min). 
Basal values
2.0 mmHg, P Ͻ 0.05) and MSA subjects (106 Ϯ 4 mmHg Mean resting supine levels of BP were similar in all groups to 83 Ϯ 5.0 mmHg, P Ͻ 0.05). There was a similar fall in (controls 130/75 Ϯ 4/1 mmHg; PSP subjects 139/76 Ϯ 4/3 heart rate in each group (controls, -9 Ϯ 1.0 beats/min; PSP mmHg; MSA subjects 138/81 Ϯ 8/5 mmHg). Resting heart subjects, -7 Ϯ 2.0 beats/min; MSA subjects, -9 Ϯ 1.6 rate was (68 Ϯ 2 beats/min) in controls and was higher in beats/min; all non-significant). PSP (75 Ϯ 1.8 beats/min) and MSA subjects (79 Ϯ 3 beats/ min) (P Ͻ 0.05 for comparison of both PSP and MSA subjects with controls).
Plasma catecholamines
Basal plasma noradrenaline levels were similar in controls and PSP subjects but were lower in MSA subjects (P Ͻ Postural change 0.005). After clonidine administration, plasma noradrenaline On head-up tilt and standing, BP was unchanged in controls fell to similar levels in controls and PSP subjects, but to and PSP subjects, unlike MSA subjects in whom there was lower levels in MSA subjects (P Ͻ 0.05). However, there a substantial fall in BP on head-up tilt (-47/27 mmHg) and was a similar percentage fall in noradrenaline in each group on standing (-66/33 mmHg) ( Table 1) . None of the PSP (controls, -65%; PSP subjects, -61%; MSA subjects, -65%). subjects had a fall in BP of Ͼ20 mmHg systolic or Basal plasma adrenaline levels in controls were not Ͼ10 mmHg diastolic. There was a similar rise in heart rate statistically different from PSP subjects and levels were with tilt in PSP subjects (4 Ϯ 1 beats/min) and controls lower in MSA subjects (P Ͻ 0.05). Following clonidine administration, plasma adrenaline levels fell in each group, (4.7 Ϯ 1.1 n.s.). GH (mU/l) Controls 3.1 (1.5) 4.5 (1.6) 7.2 (1.6) 7.4 (1.9) 6.4 (1.9) PSP subjects 3.1 (0.9) 4.9 (1.0) 5.8 (1.1) 6.9 (1.1) 3.4 (1.1) MSA subjects 3.6 (1.3) 3.6 (1.0) 3.9 (1.5) 3.7 (1.9)* 3.5 (0.6) GHRH (ng/l) Controls 15 (4) 40 (10) 32 (7) 37 ( with lower values in PSP and MSA subjects compared with
Serum GH
controls (P Ͻ 0.005 for both). Basal serum GH was similar in all groups (Table 2 and Fig. Basal plasma dopamine levels were statistically similar 1A). Following clonidine administration, individual 'raw' in controls, and PSP and MSA subjects. After clonidine GH values were distributed non-parametrically and therefore administration, levels of dopamine fell below the detection the summary value of maximum increase in GH (as the limits of the assay in each group. maximum to baseline) was calculated. The median increase There was no significant correlation between basal in GH was statistically similar in controls (6.0 Ϯ interquartile noradrenaline values and the fall in BP after clonidine range 2.8-7.1 mU/l) and PSP subjects (4.3 Ϯ interquartile administration; the Pearson correlation coefficient (r) was range 1.8-7.8 mU/l, non-significant) and was significantly 0.18 in controls, -0.09 in PSP subjects and 0.54 in MSA lower in MSA subjects (0.9 Ϯ interquartile range 0.4-2.4 mU/l, P Ͻ 0.05) (Fig. 1B) . subjects (all non-significant). Values are mean (standard error). *P Ͻ 0.05 versus control.
Plasma GHRH Discussion
This study of PSP patients indicated that none had orthostatic Basal levels of plasma GHRH were similar in all groups ( Table 2) . Because of individual variance in basal values hypotension and the majority of cardiovascular autonomic responses (except to mental arithmetic) were similar to and non-parametric distribution of GHRH data following clonidine administration, logarithmic (e) transformation of controls. The responses in MSA subjects were markedly different. Pharmacological and neurohormonal testing the summary value of maximum increase in GHRH (as maximum to baseline) was calculated. There was a greater indicated that the GH-clonidine responses were similar in PSP subjects and controls, but were significantly lower in increase in controls (3.4 Ϯ 0.3 units), than in PSP subjects (1.9 Ϯ 0.2 units, P Ͻ 0.05) and MSA subjects (2.0 Ϯ MSA subjects. The currently accepted definition of orthostatic hypotension 0.6 units, P Ͻ 0.05 in comparison with both controls and PSP subjects).
is a fall in BP of Ͼ20 mmHg systolic or Ͼ10 mmHg diastolic within 3 min of standing or on passive head-up tilting for a similar period (Schatz et al., 1996) . None of the PSP subjects
IGF-1
had orthostatic hypotension on either head-up tilt or standing. There were no differences in basal IGF-1 between controls Sandroni and colleagues reported 'insignificant orthostatic (151 Ϯ 26 ng/ml), PSP subjects (135 Ϯ 15 ng/ml) and MSA hypotension' on tilting to 80°for 5 min, although raw data subjects (147 Ϯ 24 ng/ml).
was not provided (Sandroni et al., 1991) . In PSP subjects, a greater fall in BP (mean -15/7 mmHg) on standing for 1-2 min compared with controls was reported by van Dijk
Plasma glucose
and colleagues (van Dijk et al., 1991) and Gutrecht (Gutrecht, Baseline values of glucose were similar in controls, and PSP 1992) (mean fall -8/3 mmHg). Van Dijk and colleagues did and MSA subjects (Table 2) . After clonidine administration not exclude subjects on levodopa, dopaminergic agonists or both groups showed a similar rise in glucose compared with anticholinergics (van Dijk et al., 1991) ; some of these drugs baseline (P Ͻ 0.05 for each).
may have affected cardiovascular autonomic function or lowered BP through their vasodilatory effects. In our study the confounding effects of drugs were excluded. Furthermore, Prolactin the severity of disease based on the Hoehn and Yahr scale Basal levels of prolactin were similar between the three rating (Hoehn and Yahr, 1967) was similar. Neither of the groups (Table 3) and there was no significant change BP falls reported in the studies by van Dijk and colleagues following clonidine administration.
(van Dijk et al., 1991) and Gutrecht (Gutrecht, 1992) would fulfil current criteria for orthostatic hypotension. Our results
TSH
in a large cohort of PSP patients clearly exclude orthostatic Basal levels of TSH were similar between the three groups hypotension on both head-up tilt and standing, thus indicating (Table 3) and there was no significant change following that the baroreceptor reflex and the response to postural change were functionally intact. clonidine administration.
Abnormal pressor responses to isometric exercise in PSP cardiovascular and neurohormonal responses. The basal BP in PSP subjects and controls was similar in the different subjects were reported in two previous studies (van Dijk et al., 1991; Gutrecht, 1992) . We assessed the pressor studies. In MSA subjects there was a higher basal mean arterial pressure in the clonidine study that may reflect responses to three stimuli that increased efferent sympathetic activity by different mechanisms: central command (mental increased variability, as has been described previously (Shepherd and Shepherd, 1999) . This was not observed in arithmetic), activation of peripheral ergoreceptors combined with central command (isometric exercise) and peripheral PSP subjects in whom the basal levels of BP were normal; an increased incidence of hypertension has been reported in nociception (cutaneous cold). There was a diminished pressor response to mental arithmetic in PSP subjects compared with PSP subjects, although occurring before the development of neurological impairment (Ghika and Bogousslavsky, 1997) . controls. This was unlikely to reflect an impairment of sympathetic vasoconstrictor activity as there were normal
The basal levels of plasma noradrenaline, adrenaline and dopamine were similar in PSP subjects and controls. In MSA pressor responses to isometric exercise and cutaneous cold. A possible explanation was impaired cortical activation due subjects the noradrenaline levels were lower, although not as low as the values reported in peripheral autonomic failure to cognitive deficits, as is known to occur in PSP. Formal tests of neuropsychological function were not undertaken at (Mathias et al., 1990; Thomaides et al., 1992b; Polinsky 1999) . Reduced noradrenaline levels have been reported the time of the study, but bedside testing indicated impaired cognition. Overall the data favours functional preservation previously in MSA subjects with the 'mixed' form of MSA (having parkinsonian, cerebellar and autonomic features) of central autonomic networks influencing brainstem cardiovascular autonomic centres and descending sympathetic (Kimber et al., 1997) , with higher levels in the parkinsonian and cerebellar forms; thus, the mixed form (as observed the vasoconstrictor pathways. Whether the impaired pressor responses to isometric exercise observed by van Dijk and majority of MSA subjects in this study) may reflect a more advanced form of MSA. The cardiovascular and colleagues (van Dijk et al., 1991) were due to technical difficulties, including reduced grip strength, or to other factors catecholamine response to clonidine in PSP subjects was similar to controls. Clonidine exerts these effects is unclear.
Previous studies of cardiovagal function in PSP have predominantly via a central action (Schmitt and Schmitt, 1969; Reid et al., 1977; Kooner et al., 1991) . Similar documented a decreased heart rate response to standing (ratio 30 : 15) (van Dijk et al., 1991; Gutrecht, 1992) , but normal responses occurred in MSA for reasons that are unclear, but may reflect differential effects of clonidine on the splanchnic responses to respiratory stimuli (heart rate variability during deep breathing and the Valsalva manoeuvre). In our study, circulation, which would explain the fall in BP (Thomaides et al., 1992a) , and on the spinal cord and sympathetic ganglia, the heart rate responses to head-up tilt were similar in PSP subjects and controls. Individual analyses indicated that of which would explain the fall in noradrenaline (Kooner et al., 1991) , as described previously. the 35 subjects, only four PSP subjects had abnormally low Valsalva ratios (Ͻ1.15) and reduced sinus arrythmia
The GH response to clonidine was studied as a further dynamic test of the central autonomic network and (Ͻ5 beats/min). None had evidence of other autonomic abnormalities and the reason for the abnormal cardiovagal particularly of hypothalamic-α 2 -adrenergic function. In MSA subjects there was no GH-response to clonidine, probably impairment is not clear. In the majority of PSP subjects, therefore, there was no abnormality of cardiac due to loss of medullary catecholaminergic neurons innervating the hypothalamus (Spokes et al., 1979) . In PSP parasympathetic dysfunction.
Overall, therefore, the cardiovascular responses to subjects there was a response similar to that of controls; this response was different from MSA subjects. Although the GH physiological tests of autonomic function showed neither orthostatic hypotension nor widespread abnormalities of rise in PSP subjects was not significantly different to controls, there appeared to be an altered distribution of responses (see sympathetic vasconstrictor or cardiac parasympathetic function in PSP subjects. This indicated functional integrity Fig. 1B) . The reasons for this are unclear, since basal levels of GH in PSP subjects were similar to controls, as has been of the baroreflex pathways in PSP subjects, as distinct from MSA subjects in whom there was both orthostatic hypotension previously reported (Gomez et al., 1994) . In endogenous depression there is a blunted GH response to clonidine and evidence of impairment of sympathetic and parasympathetic pathways. The autonomic abnormalities in (Matussek et al., 1980; Charney et al., 1983) that is not entirely restored despite successful treatment with MSA patients have been ascribed to involvement of supraspinal cardiovascular centres, including catechoantidepressant drugs (Checkley et al., 1981) . Depression is more common in PSP subjects than controls (Dubois et al., laminergic cells of the ventrolateral medulla (Benarroch et al., 1998) , vagal nuclei and loss of preganglionic sympathetic 1988). None of our PSP subjects was clinically depressed when studied; however, seven of the 14 cases in whom the neurons in the intermediolateral columns of the spinal cord (Daniel, 1999) . These areas appeared to be functionally clonidine-GH test was performed had been treated previously for depression with tricyclic antidepressants, although there spared in our PSP subjects.
We used clonidine as a neuropharmacological probe of was no relationship between GH responses and depression history. Animal and human studies indicate that clonidine central autonomic function, with particular attention on acts on the hypothalamus, probably through post-synaptic hypothalamic noradrenaline content, described in later studies, was not affected (Kish et al., 1985) . These α 2 -adrenoceptors (Muller, 1987) , to stimulate GH secretion through hypothalamic peptides via stimulation of GHRH or neuropathological and neurochemical reports reflect the difficulties in relating morphological deficits to functional suppression of somatostatin. Plasma levels of GHRH were measured in peripheral venous plasma. In a previous study, loss in a progressive neurological disorder, such as PSP, and emphasize the need for in vivo studies, which may be the levels following clonidine administration were less in MSA subjects than in controls (Kimber et al., 1997) , as also especially important for diagnosis, prognosis and designing strategies for treatment. was observed in our study. Levels of GHRH were also subnormal in PSP subjects. Changes in venous plasma
In conclusion, in PSP subjects, unlike MSA subjects, standard autonomic function tests did not indicate orthostatic GHRH, however, are difficult to interpret because of the extrahypothalamic contribution to peripheral levels from the hypotension. The responses to two pressor tests (isometric exercise and cutaneous cold) were preserved, but the response gastrointestinal tract, pancreas and adrenal glands. In PSP subjects there was no evidence of overall GH deficiency as to mental arithmetic was impaired; the latter favours involvement of cortical centres influencing functionally plasma levels of the peptide IGF-1 (which is generated primarily by the liver in response to circulating GH) were preserved cardiovascular autonomic centres and sympathetic vasoconstrictor efferent pathways. In the majority of subjects, similar to controls. IGF-1 exerts negative feedback effects on GH secretion in both the pituitary and hypothalamus, and cardiac parasympathetic function to various stimuli was preserved. Cardiovascular autonomic dysfunction should be as similar levels were observed in all groups, could not have accounted for the different GH responses observed. Levels an exclusion criterion for the clinical diagnosis of PSP, certainly in the early stages of the disease. Whether central of TSH and prolactin also were studied as a surrogate measure of hypothalamic somatostatin release since both autonomic impairment occurs later in the disease (as the responses to clonidine were different from MSA subjects but these hormones are inhibited by IGF-1 (Siler et al., 1974; Enjalbert et al., 1986) ; there were similar levels of IGF-1 in not identical to controls) is yet to be determined. PSP subjects and controls after clonidine administration, excluding excess release or increased sensitivity to somatostatin.
